On Thursday Addex Therapeutics (NASDAQ: ADXN) fell 20.56% to $11.90 on 14,973 shares. In the premarket of today, ADXN decides to rise by 25% minimum with the aid of the demanded volume of 4000 shares.
The stock markets are high because of biotech stocks that lure many investors to contribute and earn as much as they see on the screen. COVID-19 is driving the stock exchanges but not the actual economy that has a bucket of unemployed people who find time to protest.
ADXN has not been much popular as compared to other biotech stocks but several positive news for investors can change the whole weather in brokerage firms’ analytics.